Abbott Laboratories (NYSE: ABT) is a diversified pharmaceuticals health care company. It has 72,000 employees and operates in over 130 countries. The corporate headquarters are in Abbott Park, Illinois, located near North Chicago, Illinois. Abbott Laboratories was founded by Chicago physician Wallace Calvin Abbott in 1888. In 2008, Abbott had over $29 billion in revenue. In 1985, the company developed the first HIV blood screening test. The company's drug portfolio includes Humira, a drug for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, moderate to severe chronic psoriasis and juvenile idiopathic arthritis, Norvir, a treatment for HIV, Depakote, an anticonvulsant drug, and Synthroid, a synthetic thyroid hormone. Abbott also has a broad range of medical devices, diagnostics and immunoassay products as well as nutritional products, including Ensure, a line of well known meal replacement shakes, and EAS, the largest producer of performance based nutritional supplements. Abbott s in vitro diagnostics business is a world leader in immunoassays and blood screening.
Baxter International Inc. (NYSE: BAX), is an American health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. The company claims to have worldwide sales of $12.3 billion, across three manufacturing divisions (BioScience, producing blood plasma proteins, Medication Delivery producing intravenous therapy products and liquids, and Renal producing equipment for dialysis and the treatment of kidney disorders). The company is also involved in the production of a vaccine for the H1N1 influenza. The company was involved in several controversies. In 2001, malfunctioning dialysis machines resulted in several deaths, in 2008 the company supplied contaminated heparin, in 2009 lethal H5N1 avian flu virus was delivered to laboratories across Europe mixed with seasonal influenza vaccines, also, the company was charged with excessive billing of Kentucky Medicaid.